After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, CERO falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of CERo Therapeutics Holdings Inc is $4.78M. A total of 56771.0 shares were traded on the day, compared to an average of 1.16M shares.
In the most recent transaction, YK Bioventures Opportunities G sold 2,998,908 shares of CERO for 0.06 per share on Dec 13 ’24. After the transaction, the 10% Owner now owns 13,005,169 company shares. In a previous transaction on Dec 12 ’24, YK Bioventures Opportunities G sold 1,614,541 shares at 0.07 per share. CERO shares that 10% Owner owns now total 16,004,077.
Among the insiders who sold shares, YK Bioventures Opportunities G disposed of 1,343,801 shares on Dec 11 ’24 at a per-share price of $0.08. This resulted in the 10% Owner holding 17,618,618 shares of CERO after the transaction. In another insider transaction, YK Bioventures Opportunities G sold 1,236,874 shares at $0.12 per share on Dec 06 ’24. Company shares held by the 10% Owner now total 21,383,909.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, CERO has a high of $895.40 and a low of $6.71.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. CERO’s latest balance sheet shows that the firm has $19.22M in Cash & Short Term Investments as of fiscal 2021. There were $3.60M in debt and $1.84M in liabilities at the time. Its Book Value Per Share was -$10.36, while its Total Shareholder’s Equity was -$23.43M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CERO is Buy with a score of 5.00.
